The epidemiology of carbapenem-resistant klebsiella pneumoniae colonization and infection among long-term acute care hospital residents

Infection Control and Hospital Epidemiology

Volumn 37, Issue 1, 2016, Pages 55-60

  Mills, John P ^a   Talati, Naasha J ^a,b   Alby, Kevin ^c   Han, Jennifer H ^a,c  

^a Division of Infectious Diseases   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; CARBAPENEM; COLISTIN; FOSFOMYCIN; MEROPENEM; METRONIDAZOLE; POLYMYXIN B; TIGECYCLINE; VANCOMYCIN; ANTIINFECTIVE AGENT; CARBAPENEM DERIVATIVE; THIENAMYCIN DERIVATIVE;

ADULT; AGED; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; ARTIFICIAL VENTILATION; BACTERIAL COLONIZATION; CARBAPENEM RESISTANT ENTEROBACTERIACEAE; CASE CONTROL STUDY; COGNITIVE DEFECT; CONTROLLED STUDY; DRUG EXPOSURE; FECES INCONTINENCE; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HIGH RISK PATIENT; HUMAN; INCIDENCE; KLEBSIELLA PNEUMONIAE; KLEBSIELLA PNEUMONIAE INFECTION; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NONHUMAN; RETROSPECTIVE STUDY; RISK ASSESSMENT; STEM CELL TRANSPLANTATION; TRACHEOSTOMY; TRANSPLANTATION; DRUG EFFECTS; FECAL INCONTINENCE; HETEROZYGOTE; HOSPITAL; KLEBSIELLA INFECTIONS; MICROBIOLOGY; ORGAN TRANSPLANTATION; RISK FACTOR; STATISTICS AND NUMERICAL DATA; TIME FACTOR;

AGED; ANTI-BACTERIAL AGENTS; CARBAPENEMS; CARRIER STATE; CASE-CONTROL STUDIES; DRUG RESISTANCE, BACTERIAL; FECAL INCONTINENCE; FEMALE; HOSPITALS; HUMANS; KLEBSIELLA INFECTIONS; KLEBSIELLA PNEUMONIAE; MALE; METRONIDAZOLE; MIDDLE AGED; ORGAN TRANSPLANTATION; RESPIRATION, ARTIFICIAL; RISK FACTORS; STEM CELL TRANSPLANTATION; THIENAMYCINS; TIME FACTORS; VANCOMYCIN;

EID: 85017094401     PISSN: 0899823X     EISSN: 15596834     Source Type: Journal    
DOI: 10.1017/ice.2015.254     Document Type: Article

References (25)

1. Bogan C, Kaye KS, Chopra T, et al. Outcomes of carbapenemresistant Enterobacteriaceae isolation: matched analysis. Am J Infect Control 2014;42:612-620.
2. Borer A, Saidel-Odes L, Riesenberg K, et al. Attributable mortality rate for carbapenem-resistant Klebsiella pneumoniae bacteremia. Infect Control Hosp Epidemiol 2009;30:972-976.
3. Falagas ME, Tansarli GS, Karageorgopoulos DE, Vardakas KZ. Deaths attributable to carbapenem-resistant Enterobacteriaceae infections. Emerg Infect Dis 2014;20:1170-1175.
4. Snitkin ES, Zelazny AM, Thomas PJ, et al. Tracking a hospital outbreak of carbapenem-resistant Klebsiella pneumoniae with whole-genome sequencing. Sci Transl Med 2012;4:148ra116.
5. Tzouvelekis LS, Markogiannakis A, Psichogiou M, Tassios PT, Daikos GL. Carbapenemases in Klebsiella pneumoniae and other Enterobacteriaceae: an evolving crisis of global dimensions. Clin Microbiol Rev 2012;25:682-707.
6. Gasink LB, Edelstein PH, Lautenbach E, Synnestvedt M, Fishman NO. Risk factors and clinical impact of Klebsiella pneumoniae carbapenemase-producing K. pneumoniae. Infect Control Hosp Epidemiol 2009;30:1180-1185.
7. Yigit H, Queenan AM, Anderson GJ, et al. Novel carbapenemhydrolyzing beta-lactamase, KPC-1, from a carbapenem-resistant strain of Klebsiella pneumoniae. Antimicrob Agents Chemother 2001;45:1151-1161.
8. Lin MY, Lyles-Banks RD, Lolans K, et al. The importance of long-term acute care hospitals in the regional epidemiology of Klebsiella pneumoniae carbapenemase-producing Enterobacteriaceae. Clin Infect Dis 2013;57:1246-1252.
9. Won SY, Munoz-Price LS, Lolans K, Hota B, Weinstein RA, Hayden MK. Emergence and rapid regional spread of Klebsiella pneumoniae carbapenemase-producing Enterobacteriaceae. Clin Infect Dis 2011;53:532-540.
10. Marchaim D, Chopra T, Bogan C, et al. The burden of multidrugresistant organisms on tertiary hospitals posed by patients with recent stays in long-term acute care facilities. Am J Infect Control 2012;40:760-765.
11. Marquez P, Terashita D, Dassey D, Mascola L. Population-based incidence of carbapenem-resistant Klebsiella pneumoniae along the continuum of care, Los Angeles County. Infect Control Hosp Epidemiol 2013;34:144-150.
12. Munoz-Price LS. Long-term acute care hospitals. Clin Infect Dis 2009;49:438-443.
13. Chitnis AS, Caruthers PS, Rao AK, et al. Outbreak of carbapenem-resistant enterobacteriaceae at a long-term acute care hospital: sustained reductions in transmission through active surveillance and targeted interventions. Infect Control Hosp Epidemiol 2012;33:984-992.
14. Endimiani A, Depasquale JM, Forero S, et al. Emergence of blaKPC-containing Klebsiella pneumoniae in a long-term acute care hospital: a new challenge to our healthcare system. J Antimicrob Chemother 2009;64:1102-1110.
15. Gould CV, Rothenberg R, Steinberg JP. Antibiotic resistance in long-term acute care hospitals: the perfect storm. Infect Control Hosp Epidemiol 2006;27:920-925.
16. Performance Standards for Antimicrobial Susceptibility Testing; Twentieth Information Supplement. Clinical and Laboratory Standards Institute June 2010;M100-S20-U Vol. 30.
17. Mickey RM, Greenland S. The impact of confounder selection criteria on effect estimation. Am J Epidemiol 1989; 129:125-137.
18. Vital signs: carbapenem-resistant Enterobacteriaceae. MMWR Morb Mortal Wkly Rep 2013;62:165-170.
19. Guidance for Control of Carbapenem-resistant Enterobacteriaceae (CRE): 2012 CRE Toolkit. Centers for Disease Control and Prevention Web site. http://www.cdc.gov/hai/pdfs/cre/CREguidance-508.pdf. Accessed July 1, 2015.
20. Patel G, Huprikar S, Factor SH, Jenkins SG, Calfee DP. Outcomes of carbapenem-resistant Klebsiella pneumoniae infection and the impact of antimicrobial and adjunctive therapies. Infect Control Hosp Epidemiol 2008;29:1099-1106.
21. Mathers AJ, Cox HL, Bonatti H, et al. Fatal cross infection by carbapenem-resistant Klebsiella in two liver transplant recipients. Transpl Infect Dis 2009;11:257-265.
22. Leavitt A, Navon-Venezia S, Chmelnitsky I, Schwaber MJ, Carmeli Y. Emergence of KPC-2 and KPC-3 in carbapenemresistant Klebsiella pneumoniae strains in an Israeli hospital. Antimicrob Agents Chemother 2007;51:3026-3029.
23. Thurlow CJ, Prabaker K, Lin MY, Lolans K, Weinstein RA, Hayden MK. Anatomic sites of patient colonization and environmental contamination with Klebsiella pneumoniae carbapenemase-producing Enterobacteriaceae at long-term acute care hospitals. Infect Control Hosp Epidemiol 2013;34: 56-61.
24. Kotsanas D, Wijesooriya WR, Korman TM, et al. "Down the drain": carbapenem-resistant bacteria in intensive care unit patients and handwashing sinks. Med J Aust 2013;198: 267-269.
25. Hussein K, Sprecher H, Mashiach T, Oren I, Kassis I, Finkelstein R. Carbapenem resistance among Klebsiella pneumoniae isolates: risk factors, molecular characteristics, and susceptibility patterns. Infect Control Hosp Epidemiol 2009;30:666-671.